Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal, announced that Pakistan aims to increase its pharmaceutical exports from the current $1 billion to $30 billion in the coming years.
Speaking at the inauguration of the 22nd Health Asia 2025 exhibition at Karachi Expo Center, Kamal said the pharmaceutical and healthcare sectors hold the highest export potential in Pakistan. The event brought together participants, delegates, and companies from over 50 countries, showcasing healthcare innovations, medical devices, and pharmaceutical products.
Kamal emphasized that the government is fully committed to facilitating the industry, holding extensive consultations with stakeholders to remove export barriers. “We are ready to do everything necessary to help the industry achieve this goal,” he stated.
He also revealed plans to begin local vaccine production within the next 12 to 18 months, eliminating the need for $500 million in vaccine imports. Collaborations are underway with Chinese, Saudi Arabian, and Turkish companies to support this initiative.
Kamal expressed confidence that Pakistan will soon not only meet its domestic vaccine needs but also become an exporter, saving up to $1 billion annually as demand grows.
